GreenState reports Trump slipping with cannabis consumers

GreenState reports a drop in Trump's standing with cannabis consumers

GreenState published a report on Oct. 20 saying Trump is losing support among cannabis consumers ahead of the Nov. 3 midterms. CannIntel could review only the headline.

That limits what can be said. The underlying survey figures, the sample, and the baseline the outlet compared against weren't available in the material reviewed here. We aren't going to supply numbers that the source didn't.

What can be said is narrower, and still worth tracking. A national news outlet that covers cannabis for a consumer audience is describing a measurable slide, and it is doing so inside the final two weeks of a federal election cycle.

The missing data decides how much the finding means

A drop in "support" can mean very different things depending on who was surveyed and what they were compared against. Readers should look for three details in the original report before drawing conclusions.

The first is the population: self-identified cannabis consumers, registered voters who use cannabis, or likely midterm voters. The second is the comparison point, whether that's 2024 vote choice, a prior poll, or a favorability rating. The third is the margin of error, which in a subgroup of a national sample can be large enough to swallow a modest shift.

Not yet. Until those are on the table, the result is a direction, not a measurement.

Rescheduling is the policy record consumers are judging

The administration's central cannabis action is the move to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act. The process began when the Department of Health and Human Services recommended the change in August 2023, and the DEA published a proposed rule in May 2024.

Trump then signed an executive order in December 2025 directing the attorney general to expedite the rescheduling. CannIntel's signal doesn't say where the rule stands as of Oct. 20, so the DEA's rulemaking docket is the place to confirm its current status.

Here's the structural problem for any politician claiming credit. Schedule III would largely end the 280E tax penalty that bars state-licensed plant-touching businesses from deducting ordinary expenses, which is a balance-sheet event for operators. It wouldn't legalize adult-use sales or change any state's possession laws, and it wouldn't lower a price at the dispensary counter. A consumer could reasonably look at that record and see nothing that touched their own experience.

Consumer sentiment is a thin reed for operators and investors

Cannabis consumers don't vote as a single bloc, and a softening among them doesn't translate cleanly into a policy shift. Midterm ballots decide congressional seats and state offices, while the rules consumers care about most, such as licensing, taxes, and possession limits, are set mostly at the state level.

For investors in multistate operators, the more relevant question is whether Congress moves on banking or tax legislation after the election, not whether a poll subgroup shifts a few points. For patients, the questions are access and affordability, and neither turns on a national favorability number. A sentiment dip can still shape how candidates talk about cannabis in a lame-duck session, which is where a lot of stalled federal cannabis language has historically been tested. That math is hard to ignore.

To see how cannabis consumers are factoring into this cycle, read the CannIntel topic hub on cannabis voters and the 2026 midterms.

What to watch before Nov. 3

Three documents will show whether the GreenState finding holds up: the original poll methodology, the DEA docket, and any new cannabis messaging from campaigns. Each can be checked against a primary source rather than a headline.

If the methodology shows a likely-voter sample with a meaningful subgroup size, the result deserves weight. If it rests on a small slice of a larger survey, it deserves caution. The DEA docket will show whether the rescheduling record is still moving or has stalled, and that will shape what either party can say to consumers in the last two weeks.

The next signal: any follow-up polling released between now and Nov. 3 that isolates cannabis consumers, and whether it confirms the direction GreenState described.